Earnings Labs
Enliven Therapeutics, Inc. logo

Enliven Therapeutics, Inc. (ELVN) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$42.91

-4.43%

Mkt Cap $2.74B

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 3, 2026

$12.50K-$0.42-$0.48-14.29%
Q4 2025

Nov 12, 2025

$8.33K-$0.43-$0.32+25.58%
Q3 2025

Aug 13, 2025

-$0.53-$0.49+7.55%
Q2 2025

May 14, 2025

-$0.51-$0.57-11.76%
Q1 2025

Mar 13, 2025

-$0.53-$0.46+13.21%
Q4 2024

Nov 13, 2024

-$0.52-$0.48+7.69%
Q3 2024

Aug 13, 2024

-$0.58-$0.41+29.31%
Q2 2024

May 14, 2024

-$0.58-$0.54+6.90%
Q1 2024

Mar 14, 2024

$440.00K-$0.56-$0.47+16.07%
Q4 2023

Nov 9, 2023

-$0.49-$0.51-4.08%
Q3 2023

Aug 10, 2023

-$0.40-$0.41-2.50%
Q2 2023

May 11, 2023

-$0.67-$0.80-19.40%
Q1 2023

Feb 10, 2023

-$0.79$1.23+256.49%
Q4 2022

Oct 25, 2022

-$1.00-$0.72+28.00%
Q3 2022

Aug 3, 2022

-$2.05-$1.76+14.15%
Q2 2022

May 6, 2022

-$2.31-$2.24+3.03%
Q1 2022

Mar 15, 2022

-$3.00-$2.12+29.33%
Q4 2021

Nov 9, 2021

-$3.38-$2.20+34.91%
Q3 2021

Aug 6, 2021

-$3.20-$2.96+7.50%
Q2 2021

May 11, 2021

-$3.34-$2.32+30.54%
Q1 2021

Mar 5, 2021

-$3.35-$2.24+33.13%
Q4 2020

Nov 5, 2020

-$3.21-$2.88+10.28%
Q3 2020

Aug 14, 2020

-$2.25-$2.36-4.89%
Q2 2020

May 7, 2020

-$2.94-$17.24-486.39%
Q1 2020

Mar 11, 2020

-$1.53
Q4 2019

Dec 31, 2019

-$1.68
Q2 2019

Jun 30, 2019

-$1.25
Q1 2019

Mar 31, 2019

-$0.97